🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
70.50
-0.30 (-0.42%)
Nov 20, 2026, 1:24 PM CST

WeLeader Biomedical Revenue

WeLeader Biomedical had revenue of 352.70M TWD in the quarter ending September 30, 2026, with 19.20% growth. This brings the company's total for the last twelve months to 1.27B, up 19.20% year-over-year. In the year 2025, WeLeader Biomedical had annual revenue of 1.11B with 11.92% growth. That makes WeLeader Biomedical the 29,867th largest company in the world by revenue and 1,459th in Taiwan.

Revenue (ttm)
1.27B
Revenue Growth
+19.20%
P/S Ratio
2.53
Revenue / Employee
n/a
Employees
201
Market Cap
3.21B

Revenue Chart

Revenue by Segment

  • The Company 921.45M 82.7%
  • Health Leader Biomedical Co., Ltd. 192.86M 17.3%
Fiscal year ended Dec 31, 2025 See the full WeLeader Biomedical breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.11B118.18M11.92%
Dec 31, 2024991.13M50.43M5.36%
Dec 31, 2023940.70M-95.02M-9.17%
Dec 31, 20221.04B194.58M23.13%
Dec 31, 2021841.14M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.